Takeda Pharmaceuticals developed Actos to treat Type 2 Diabetes. Approved by the FDA in July of 1999, it was designed to help diabetics regulate the insulin in their bodies when other drugs failed. Actos was an economically successful drug for Takeda Pharmeceuticals until long term studies came to light linking Actos users to bladder cancer, heart attacks, and other health problems.
The FDA recently cited a five year study of more than 193,000 patients over the age of 40. Patients that took Actos for more than twelve months were 40% more likely to develop bladder cancer. Since this study, France has banned Actos, and the FDA now requires Takeda include information about the risks of bladder cancer in its Actos packaging. Further studies are still being conducted.
Bladder cancer symptoms include:
- blood in urine,
- urgency to urinate,
- painful urination, and
- pain in the lower back or abdomen.
If you have been taking Actos for more than a year for your Type 2 Diabetes and are experiencing any of these symptoms, contact your doctor immediately to get tested for bladder cancer. The sooner you are diagnosed and treated, the better your prognosis viagra net.
Patients who have developed health problems, such as bladder cancer, may be entitled to compensation for their medical bills, lost income, as well as pain and suffering. Cancer treatment can take a long time and is extremely expensive. Should the patient die before resolution of the case, his or her family may be entitled to damages.